NRXS NeurAxis, Inc.
Healthcare$7.00-5.15%ClosedMarket Cap: $86.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
14.06
P/S
21.35
EV/EBITDA
-11.84
DCF Value
$-4.81
FCF Yield
-6.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
85.0%
Operating Margin
-169.9%
Net Margin
-170.1%
ROE
-185.7%
ROA
-83.3%
ROIC
-119.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.6M | 86.4% | $-1.7M | $-1.8M | $— | — |
| Q4 null | $968.1K | 85.4% | $-1.7M | $-1.7M | $— | — |
| FY null | $3.6M | 84.2% | $-7.8M | $-7.8M | $— | — |
| Q3 null | $811.4K | 83.3% | $-2.1M | $-2.1M | $— | — |
| Q2 null | $894.1K | 83.6% | $-1.7M | $-1.7M | $— | — |
| Q1 null | $895.7K | 84.4% | $-2.3M | $-2.3M | $— | — |
| Q4 null | $761.2K | 86.2% | $-1.5M | $-1.4M | $— | — |
| FY null | $2.7M | 86.5% | $-7.2M | $-8.2M | $— | — |
| Q3 null | $666.6K | 85.4% | $-1.7M | $-1.8M | $— | — |
| Q2 null | $611.5K | 88.0% | $-2.2M | $-2.9M | $— | — |
| Q1 null | $646.6K | 88.4% | $-1.8M | $-2.1M | $— | — |
| Q4 2023 | $531.5K | 86.4% | $-1.6M | $-5.3M | $-0.84 | — |